3-Deazaneplanocin A (DZNep): A Drug That Deserves a Second Look.
Sign Up to like & getrecommendations! Published in 2024 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.4c01566
Abstract: The emerging data compiled during the past five years on 3-deazaneplanocin (DZNep) provide compelling evidence to reevaluate this drug as a better alternative over the specific catalytic inhibitors of histone methyl transferases (HTMs). The indirect… read more here.
Keywords: dznep drug; deserves second; drug deserves; deazaneplanocin dznep ... See more keywords